Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Xynomic Pharmaceuticals Holdings, Inc. (XYNO) had Tangible Shareholders Equity of $-22.56M for the most recently reported fiscal quarter, ending 2019-12-31.
| Income Statement Financials | |
-- |
|
$-18.91M |
|
-- |
|
-- |
|
$16.84M |
|
$-16.84M |
|
$-0.37M |
|
$-17.21M |
|
$-17.22M |
|
$-17.21M |
|
$-17.21M |
|
$-17.21M |
|
$-17.22M |
|
$-16.84M |
|
$-16.85M |
|
32.28M |
|
32.28M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$0.42M |
|
$0.29M |
|
$0.51M |
|
$0.94M |
|
$23.50M |
|
-- |
|
-- |
|
$23.50M |
|
$-22.56M |
|
|
Tangible Shareholders Equity |
$-22.56M |
$-22.56M |
|
46.27M |
|
| Cash Flow Statement Financials | |
$-10.67M |
|
$63.26M |
|
$-57.22M |
|
$4.75M |
|
$0.09M |
|
$-4.65M |
|
$8.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-- |
|
-0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.72M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
76.29% |
|
76.29% |
|
-1836.24% |
|
76.29% |
|
$-0.49 |
|
$-0.33 |
|
$-0.33 |
|